- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
EVIO Obtains Mandatory Laboratory Accreditation in Massachusetts
EVIO announced its Massachusetts laboratory obtained the mandatory accreditation needed to operate as a testing laboratory.
EVIO (OTCQB:EVIO) announced its Massachusetts laboratory obtained the mandatory accreditation needed to operate as a testing laboratory.
As quoted in the press release:
EVIO a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, announced today that its Massachusetts laboratory has attained ISO/IEC 17025 accreditation from American Association for Laboratory Accreditation (A2LA). ISO 17025 accreditation is mandatory in Massachusetts for all independent testing laboratories.
ISO/IEC 17025 is the highest recognized quality standard in the world for calibration and testing laboratories. For an organization to be accredited in ISO/IEC 17025, its laboratory is assessed to determine they can consistently produce precise and accurate tests for cannabinoids, pesticides, and contaminants, and have implemented a rigorous quality management system. This also requires personnel to be deemed competent to perform all testing on the scope of accreditation.
“We are very proud of all of the teams’ hard work that resulted in this advanced accreditation,” said James Kocis, Lab Director of EVIO Labs Massachusetts. “With the state-mandated laboratory regulations, EVIO upholds the high standards of testing and plays a pivotal role in ensuring consumer safety and confidence in the states burgeoning marijuana market.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.